Mindfulness - Based Stress Reduction Safe, Effective for Anxiety Disorders
In randomized study, mindfulness - based stress reduction is noninferior to escitalopram (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2022 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

Mindfulness meditation is as effective as LEXAPRO at alleviating anxiety, study finds 
Researchers in Washington DC found people who meditated every day and did yoga once a week saw their anxious thoughts and feelings ease by almost a third after six weeks. (Source: the Mail online | Health)
Source: the Mail online | Health - November 10, 2022 Category: Consumer Health News Source Type: news

Mindfulness Worked as Well as an Anxiety Drug in a New Study
Mindfulness meditation worked as well as a standard drug for treating anxiety in the first head-to-head comparison. The study tested a widely used mindfulness program that includes 2 1/2 hours of classes weekly and 45 minutes of daily practice at home. Participants were randomly assigned to the program or daily use of a generic drug sold under the brand name Lexapro for depression and anxiety. After two months, anxiety as measured on a severity scale declined by about 30% in both groups and continued to decrease during the following four months. Study results, published Wednesday in the journal JAMA Psychiatry, are timely....
Source: TIME: Health - November 9, 2022 Category: Consumer Health News Authors: Lindsey Tanner/AP Tags: Uncategorized healthscienceclimate Mental Health wire Source Type: news

To calm anxiety, researchers find meditation as effective as Lexapro : Shots - Health News
#lexapro #shotshealthnews (Source: Reuters: Health)
Source: Reuters: Health - November 9, 2022 Category: Consumer Health News Source Type: news

Mindfulness-Based Stress Reduction Is As Effective As Antidepressants For Anxiety Disorders, Study Finds
Results show meditation reduced anxiety as much as the common antidepressant drug escitalopram. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 9, 2022 Category: Pharmaceuticals Authors: Ty Roush, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news

Title: escitalopramCategory: MedicationsCreated: 3/16/2003 12:00:00 AMLast Editorial Review: 8/20/2022 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - August 20, 2022 Category: Psychiatry Source Type: news

Antidepressant, Exercise Help Combat Anxiety in CHD Antidepressant, Exercise Help Combat Anxiety in CHD
Both escitalopram and exercise may help lower anxiety in adults with coronary heart disease (CHD) and high levels of anxiety ― but escitalopram has the greater impact, new research suggests.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 27, 2021 Category: Internal Medicine Tags: Psychiatry News Source Type: news

The 10 Most Important Health Breakthroughs You Missed During the Pandemic
While most eyes were on COVID-19, researchers have also made groundbreaking advancements in other fields. Here’s a look. The other big vaccine news Public-health officials have long sought a vaccine against malaria, which infects up to 600 million people a year and kills 400,000, mostly children. This year, there was dramatic prog­ress toward that goal. In a study of 450 children in Burkina Faso, published in the Lancet in April, researchers reported that a new malaria vaccine, called R21, is 77% effective—just clearing the World Health Organization’s 75% efficacy standard. However, the sa...
Source: TIME: Health - June 10, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized COVID-19 feature Innovation Magazine Source Type: news

The Psychedelic Drug Trial review – a mind-bending magic mushroom mission
Helmed by Prof David Nutt, this documentary follows volunteers as they swap antidepressants for psilocybin ... and it ’s the closest they’ve come to joy in yearsIn 2008, Prof David Nutt was made chair of the government ’s Advisory Council on the Misuse of Drugs. A year later, Nutt, a neuropsychopharmacologist, was sacked by the same government after insisting – I paraphrase minimally – that fags and booze were more dangerous than cannabis and ecstasy. Twelve years on, he is still clearly furious about it – not the sacking, but the lack of evidence-based thinking behind it. “I just couldn’t bear to mislead t...
Source: Guardian Unlimited Science - May 19, 2021 Category: Science Authors: Lucy Mangan Tags: Television & radio Culture Science Drugs Society Psychology Pharmacy and pharmacology Source Type: news

Author Q & A: New generation antidepressants for depression in children and adolescents
In this author interview we find out more about this recently published Network Meta-analysis,New generation antidepressants for depression in children and adolescents. Authors Dr. Sarah Hetrick and Nick Meader tell us about this work.What were you trying to find out with this Network Meta-Analysis?We were trying to find out how well newer generation antidepressants work compared with placebo and if some are more effective than others. We wanted to know how these antidepressants affect:symptoms of depression;recovery: no longer meeting diagnostic criteria for major depressive disorder;response or remission: scores on a sca...
Source: Cochrane News and Events - May 11, 2021 Category: Information Technology Authors: Rachel Klabunde Source Type: news

Psilocybin Compared With Escitalopram for Depression
No difference seen in change in depression scores at six weeks for psilocybin plus placebo versus psilocybin plus escitalopram (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - April 15, 2021 Category: Psychiatry Tags: Pharmacy, Psychiatry, Journal, Source Type: news

Psilocybin Compared With Escitalopram for Depression
THURSDAY, April 15, 2021 -- For patients with major depressive disorder, the change in scores for depression at six weeks does not differ significantly with psilocybin or psilocybin plus escitalopram, according to a study published in the April 15... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 15, 2021 Category: Pharmaceuticals Source Type: news

Magic mushrooms show promise in treatment for depression, study says
Trial suggests psilocybin combined with psychological therapy is as effective as antidepressant drugMagic mushrooms have a long and rich history. Now scientists say they could play an important role in the future, with their active ingredient a promising treatment for depression.The results from a small, phase two clinical trial have revealed that two doses of psilocybin appears to be as effective as the common antidepressant escitalopram in treating moderate to severe major depressive disorder, at least when combined with psychological therapy.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 14, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Depression Medical research Science UK news Psychology Drugs Society Source Type: news

Escitalopram-induced severe akathisia leading to suicide attempt - Pratap A, Akhtar S, Sinha P, Bakhla AK.
We report a case of... (Source: SafetyLit)
Source: SafetyLit - November 28, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Antidepressants for Dementia Prevention? Antidepressants for Dementia Prevention?
The SSRI escitalopram appears to lower amyloid-beta levels in cerebrospinal fluid of cognitively normal older adults, suggesting a potential role for these drugs in preventing Alzheimer ' s disease.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 18, 2020 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news